Imara, Inc. (NASDAQ:IMRA)

About the company

Imara, Inc. engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. Its product candidate, IMR-687 is a highly selective and small molecule inhibitor of PDE9. The company was founded by James G. McArthur in 2016 and is headquartered in Cambridge, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

16

CEO

Rahul D. Ballal

Exchange

NASDAQ

Website

http://www.imaratx.com

$NoneM

Total Revenue

16

Employees

$438.60M

Market Capitalization

-12.46

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 383533.80 82729.00 6.16 22.35 20.75
Merck & Co., Inc. MRK 199942.72 48081.00 7.51 19.73 21.10
Pfizer Inc. PFE 190383.75 50660.00 2.88 12.05 31.17
Eli Lilly & Co. LLY 155261.34 23087.00 52.69 27.37 23.97
AbbVie, Inc. ABBV 147435.40 34057.00 -23.60 17.58 24.65
Bristol Myers Squibb Co. BMY 111198.52 31006.00 2.70 94.54 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4363.04 137.00 3.41 -9.50 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 4053.40 1.00 37.48 -6.20 None
Allakos, Inc. ALLK 3236.42 None 7.03 -34.60 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2484.72 891.00 1.77 -8.50 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.72 None 6.80 -18.91 None
IGM Biosciences, Inc. IGMS 2237.27 None 9.86 -41.24 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1784.50 None 5.80 -28.62 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1578.64 30.00 5.62 -22.46 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1544.38 None 9.46 -16.76 None
Akcea Therapeutics, Inc. AKCA 1347.82 341.00 2.77 -47.91 -8.59
Tricida, Inc. TCDA 1319.57 None 6.78 -6.25 None
Kiniksa Pharmaceuticals Ltd. KNSA 1279.85 None 6.63 -10.58 None
Arcutis Biotherapeutics, Inc. ARQT 1154.40 None 4.92 -18.46 None
Akero Therapeutics, Inc. AKRO 1135.64 None 9.48 -22.38 None
Odonate Therapeutics, Inc. ODT 1127.52 None 9.24 -10.02 None
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Constellation Pharmaceuticals, Inc. CNST 983.36 None 4.63 -10.60 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Quanterix Corp. QTRX 732.51 60.00 6.46 -16.75 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 711.70 14.00 4.60 -14.44 -19.41
Aprea Therapeutics, Inc. APRE 689.64 None 6.10 -20.40 None
Oric Pharmaceuticals, Inc. ORIC 687.96 None -7.47 -22.75 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Arcturus Therapeutics Holdings, Inc. ARCT 665.08 19.00 61.64 -23.91 -151.34
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 617.87 1679.00 4.25 -2.84 -11.85
Keros Therapeutics, Inc. KROS 606.78 8.00 -27.41 -28.57 -285.35
Oyster Point Pharma, Inc. OYST 548.10 None 5.51 -9.53 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Fulcrum Therapeutics, Inc. FULC 476.10 1.00 8.02 -6.90 None
89bio, Inc. ETNB 462.70 None 5.71 -7.17 None
Biospecifics Technologies Corp. BSTC 462.28 40.00 3.75 19.77 61.80
SIGA Technologies, Inc. SIGA 460.84 19.00 5.16 -23.42 -94.00
Satsuma Pharmaceuticals, Inc. STSA 441.32 None 4.34 -12.13 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
DURECT Corp. DRRX 405.48 28.00 31.14 -16.77 -82.94
Relmada Therapeutics, Inc. RLMD 394.02 0.00 5.88 -32.92 -877.66
Kala Pharmaceuticals, Inc. KALA 383.04 6.00 4.19 -4.17 None
TCR2 Therapeutics, Inc. TCRR 368.64 None 2.52 -36.57 None
Ocular Therapeutix, Inc. OCUL 367.20 6.00 -45.00 -4.01 None
Ovid Therapeutics, Inc. OVID 344.25 None 8.14 -5.28 None
Osmotica Pharmaceuticals Plc OSMT 343.44 232.00 2.61 -1.25 -115.44
Aeglea Biotherapeutics, Inc. AGLE 303.27 4.00 9.57 -3.78 -523.27
Urovant Sciences Ltd. UROV 295.80 None -5.24 -2.05 None
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Lannett Co., Inc. LCI 242.82 542.00 0.83 -7.99 -5.77
Gritstone Oncology, Inc. GRTS 226.44 4.00 2.03 -2.17 None
KalVista Pharmaceuticals, Inc. KALV 211.68 12.00 2.34 -6.53 -263.38
Kaleido Biosciences, Inc. KLDO 207.90 None 7.37 -2.84 None
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Sutro Biopharma, Inc. STRO 194.81 41.00 3.70 -3.20 -148.06
Protara Therapeutics, Inc. TARA 191.34 None 2.88 -12.41 None
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 175.03 1.00 5.28 -4.11 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
scPharmaceuticals, Inc. SCPH 156.37 119.00 4.00 -4.99 -27.05
Avenue Therapeutics, Inc. ATXI 155.20 532.00 28.53 -10.66 26.69
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Lyra Therapeutics, Inc. LYRA 144.84 1.00 -1.23 -8.68 -491.16
Evelo Biosciences, Inc. EVLO 144.00 None 5.29 -1.64 None
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 128.00 None 2.99 -2.60 None
TFF Pharmaceuticals, Inc. TFFP 117.80 None 4.56 -3.04 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Ayala Pharmaceuticals, Inc. AYLA 115.41 3.00 -2.72 -5.59 -679.19
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Milestone Pharmaceuticals, Inc. MIST 95.00 None 0.94 -1.53 None
Eton Pharmaceuticals, Inc. ETON 94.32 1.00 10.27 -4.72 None
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Clearside Biomedical, Inc. CLSD 76.67 6.00 9.84 -4.35 -293.61
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Baudax Bio, Inc. BXRX 65.70 None -1.79 -0.94 None
Navidea Biopharmaceuticals, Inc. NAVB 64.60 1.00 -47.50 -5.85 -65.13
BiomX, Inc. PHGE 60.06 None 1.58 -1.40 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 53.71 20.00 1.62 -2.85 -51.58
Menlo Therapeutics, Inc. MNLO 49.30 2.00 4.15 -0.53 -483.51
Annovis Bio, Inc. ANVS 47.46 None 4.35 -37.67 None
Edesa Biotech, Inc. EDSA 45.36 0.00 6.46 -0.48 -395.23
Eyenovia, Inc. EYEN 44.20 None 4.46 -2.16 None
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
AgeX Therapeutics, Inc. AGE 33.82 2.00 -44.50 -2.78 -658.11
Allena Pharmaceuticals, Inc. ALNA 33.81 None 4.45 -0.78 None
Mannatech, Inc. MTEX 33.70 156.00 1.42 7.59 3.45
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Acer Therapeutics, Inc. ACER 32.20 3.00 2.35 -1.23 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.20 0.00 0.59 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.64 0.00 0.93 -0.94 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 17.04 9.00 1.54 -5.68 -31.15
Adial Pharmaceuticals, Inc. ADIL 15.00 None 3.66 -1.97 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.33 5.00 -3.29 -0.45 -602.34
PDS Biotechnology Corp. PDSB 13.30 None 1.47 -0.52 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 7.44 None 0.64 -0.35 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Here is What Hedge Funds Think About IMARA Inc. (IMRA)

16d ago, source: YAHOO!

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use ...

Imara Added to Membership of U.S. Small-Cap Russell 2000® Index

9d ago, source: YAHOO!

Imara Inc. (IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of ...

Imara reports promising data from mid-stage trial for sickle cell treatment

27d ago, source: MSN

Imara Inc. (imra) announced positive interim results from a mid-stage clinical trial for its experimental sickle cell disease treatment. The Phase 2a study is testing IMR-687, an oral treatment ...

Imara Receives Orphan Drug Designation for IMR-687 for Treatment of Beta-thalassemia

15d ago, source: Nasdaq

BOSTON, Mass., June 24, 2020 (GLOBE NEWSWIRE) -- IMARA Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat ...

Imara Announces Recipients of Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders

14d ago, source: Benzinga.com

BOSTON, June 25, 2020 (GLOBE NEWSWIRE) -- IMARA Inc. (NASDAQ:IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients ...

IMARA Inc Registered Shs Outperform

27d ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net Summary: IMARA Inc Registered Shs Outperform Analyst Opinions for IMARA Inc Registered ShsMore Latest Analyst Opinions 06 ...

Is Sterling Construction Company, Inc. (STRL) Going to Burn These Hedge Funds?

11d ago, source: Insider Monkey

In this article we will check out the progression of hedge fund sentiment towards Sterling Construction Company, Inc. (NASDAQ:STRL) and determine whether it is a good investment right now.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.